EMA Application withdrawn: Mersarex — Arpida A/S

View source ↗

Summary

The EMA status shows withdrawal of the Mersarex application by Arpida A/S for skin infections and soft tissue infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Infections
• Soft Tissue Infections

Drugs mentioned

• Mersarex (iclaprim)

Snippet

Status: Application withdrawn. Therapeutic area: Skin Diseases, Bacterial;Soft Tissue Infections. MAH: Arpida A/S. Decision date: 31/12/2009